Thursday, Sept 12, 2024
3:30 – 4:00 PAH Update
Roger Alvarez, MD
4:00 – 4:30 IPF: Current and future management
David Zisman, MD
4:30 – 5:00 Navigating the waters of drug-induced pulmonary toxicity
Abigail Koch, MD
5:00 – 5:15 Panel Discussion: Q & A
5:15 – 5:45 CTEPH: Latest updates and therapies
Roger Alvarez, MD
5:45 – 6:15 Emerging perspectives in secondary immunodeficiency
Antoine Azar, MD
6:15 – 6:30 Panel Discussion: Q & A
Friday, Sept 13, 2024
7:45 – 8:15 Monoclonal antibodies in asthma management
Rey Panettieri, MD
8:15 – 8:45 The future is now: AI and machine learning in pulmonary medicine
Momen Wahidi, MD
8:45 – 8:55 Panel Discussion: Q & A
8:55 – 10:00 PBL: A 38 -year-old woman with asthma
Ray Davis, MD, Don Bukstein, MD, Rey Panettieri, MD, Russ Settipane, MD
10:00 – 10:45 Coffee Break: Visit exhibits and posters
10:45 – 11:15 Airways disease and rescue approaches
Rey Panettieri, MD
11:15 – 11:55 ARDS unfolded: New definitions and phenotypes
Neil MacIntyre, MD
11:55 – 12:25 Cystic fibrosis in the young and old
Jeffrey Hoag, MD
12:25 – 12:35 Panel Discussion: Q & A
1:30 – 2:15 Critical care in review
Michael Pinsky, MD
2:15 – 2:45 Mechanical ventilation: What’s new?
Neil MacIntyre, MD
2:45 – 3:00 Panel Discussion: Q & A
Saturday, Sept 14, 2024
7:45 – 8:15 Asthma exacerbations: The infectious side
Monica Kraft, MD
8:15 – 8:45 Cell-based and monoclonal therapeutic approaches in lung cancer
Charles Powell, MD
8:45 – 8:55 Panel Discussion: Q & A
8:55 – 10:00 PBL: A 45-year-old woman with frequent COPD exacerbations
Ray Davis, MD, Don Bukstein, MD, Rey Panettieri, MD, Russ Settipane, MD
10:00 – 10:45 Coffee Break: Visit exhibits and posters
10:45 – 11:45 New COPD guidelines
Barry Make, MD
11:45 – 12:15 Monoclonal antibodies in COPD management
Nick Hanania, MD
12:15 – 12:25 Panel Discussion: Q & A
1:20 – 1:50 Sarcoidosis
Mehdi Mirsaeidi, MD
1:50 – 2:20 Gizmos and gadgets for airway clearance
Ashwin Basavaraj, MD
2:20 – 2:30 Panel Discussion: Q & A
___________________________________________________________________________________________
2:30 - 5:00 *Fellows program - *NOT for CME
2:30 - 2:35 Welcome Remarks and Introduction
Anas Hadeh, MD
2:35 - 3:05 COPD with Type 2 Inflammation: A Spark for Deeper COPD Understanding
Reynold Panettieri, Jr., MD
Supported by Sanofi and Regeneron
3:05 - 3:50 Problem Based Learning (PBL): Recurrent Pneumonia in a Young Adult
Richard Wasserman, MD and Elena Perez, MD
Supported by Grifols
3:50 - 4:10 Tips for Success in the Ambulatory Clinic
Anas Hadeh, MD
4:10 - 4:55 Pulmonary and Critical Care Olympiad
Mauricio Danckers, MD
4:55 - 5:00 Awards Distribution
Sunday, Sept 15, 2024
8:15 – 8:45 Complications of bronchoscopy
Momen Wahidi, MD
8:45 – 9:15 OSA and gender
Carolyn D'Ambrosia, MD
9:15 – 9:45 Diagnosis and management of hypersensitivity pneumonitis
Amanda Wu, MD
9:45 – 10:15 NTM lung disease: Is the treatment worse than the disease?
Joseph Khabbaza, MD
10:15 – 10:30 Panel Discussion: Q & A
_____________________________________________________________________________________
Sunday, Sept 15, 2024
CME Symposia provided by Academic CME
1030 - 12:00 noon
Critical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnosis, Pathophysiology, and Clinical Trial Analysis of Newer Therapies
Jeffrey Hoag, MD
* Supported by an independent educational grant from Insmed
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
James R. Klinger, MD
* Supported by an independent educational grant from Merck & Co, Inc.
Clinical Strategies for Newer Maintenance Therapies to Reduce Exacerbations in Patients with COPD
Nick Hanania, MD
* Supported by an independent educational grant from Mylan Specialty LP, a Viatris
Company
______________________________________________________________________________________________________